Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

X Poire; M Labopin; E Polge; J Passweg; C Craddock; D Blaise; Jan Cornelissen; L Volin; NH Russell; G Socie; M Michallet; N Fegueux; P Chevallier; A Brecht; M Hunault-Berger; M Mohty; J Esteve; A Nagler

doi:10.3324/haematol.2017.178251

Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

X Poire, M Labopin, E Polge, J Passweg, C Craddock, D Blaise, Jan Cornelissen, L Volin, NH Russell, G Socie, M Michallet, N Fegueux, P Chevallier, A Brecht, M Hunault-Berger, M Mohty, J Esteve, A Nagler

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	256-265
Number of pages	10
Journal	Haematologica
Volume	103
Issue number	2
DOIs	https://doi.org/10.3324/haematol.2017.178251
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.3324/haematol.2017.178251

http://hdl.handle.net/1765/104502

Cite this

Poire, X., Labopin, M., Polge, E., Passweg, J., Craddock, C., Blaise, D., Cornelissen, J., Volin, L., Russell, NH., Socie, G., Michallet, M., Fegueux, N., Chevallier, P., Brecht, A., Hunault-Berger, M., Mohty, M., Esteve, J., & Nagler, A. (2018). Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica, 103(2), 256-265. https://doi.org/10.3324/haematol.2017.178251

@article{63c63df4e98e4920b65060e485e3a517,

title = "Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation",

author = "X Poire and M Labopin and E Polge and J Passweg and C Craddock and D Blaise and Jan Cornelissen and L Volin and NH Russell and G Socie and M Michallet and N Fegueux and P Chevallier and A Brecht and M Hunault-Berger and M Mohty and J Esteve and A Nagler",

year = "2018",

doi = "10.3324/haematol.2017.178251",

language = "Undefined/Unknown",

volume = "103",

pages = "256--265",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "2",

}

Poire, X, Labopin, M, Polge, E, Passweg, J, Craddock, C, Blaise, D, Cornelissen, J, Volin, L, Russell, NH, Socie, G, Michallet, M, Fegueux, N, Chevallier, P, Brecht, A, Hunault-Berger, M, Mohty, M, Esteve, J & Nagler, A 2018, 'Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation', Haematologica, vol. 103, no. 2, pp. 256-265. https://doi.org/10.3324/haematol.2017.178251

Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. / Poire, X; Labopin, M; Polge, E et al.
In: Haematologica, Vol. 103, No. 2, 2018, p. 256-265.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

AU - Poire, X

AU - Labopin, M

AU - Polge, E

AU - Passweg, J

AU - Craddock, C

AU - Blaise, D

AU - Cornelissen, Jan

AU - Volin, L

AU - Russell, NH

AU - Socie, G

AU - Michallet, M

AU - Fegueux, N

AU - Chevallier, P

AU - Brecht, A

AU - Hunault-Berger, M

AU - Mohty, M

AU - Esteve, J

AU - Nagler, A

PY - 2018

Y1 - 2018

U2 - 10.3324/haematol.2017.178251

DO - 10.3324/haematol.2017.178251

M3 - Article

C2 - 29242299

SN - 0390-6078

VL - 103

SP - 256

EP - 265

JO - Haematologica

JF - Haematologica

IS - 2

ER -

Poire X, Labopin M, Polge E, Passweg J, Craddock C, Blaise D et al. Allogeneic stem cell transplantation benefits for patients >= 60 years with acute myeloid leukemia and FLT3 internal tandem duplication: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Haematologica. 2018;103(2):256-265. doi: 10.3324/haematol.2017.178251